Changes in the GLP-1 market New FDA-approved GLP-1 pills
Preserves the pulsatile pattern more faithfully, which some clinicians prefer for its more physiologic GH release profile
In 2024, Independence Health Group, the for-profit parent company of the nonprofit Philadelphia-based health insurance company Independence Blue Cross, reported a net loss of $239 million, despite generating $32 billion of revenue, citing a sharp increase in medical and pharmacy costs. One driver behind these losses is the rapid growth of weight-loss medications, including glucagon-like peptide-1 receptor agonists, known as GLP-1s, such as Ozempic
I prefer to recommend medication use as close to the manufacturers recommendations as possible, or that which is supported by research. The dietician perspective on microdosing GLP-1 But Jaclyn Pritchard, registered dietician and leader of the weight management program at Cleveland Clinic Canada, thinks there is room for personalization when taking GLP-1 medications
A study has recently demonstrated that curcumin-based gold nanoparticles (cur-AuNPs) could inhibit PC cell growth